Please enable JavaScript.
Coggle requires JavaScript to display documents.
alpha-glucosidase inhibitors arcarbose meglitinides repaglinide…
alpha-glucosidase inhibitors arcarbose meglitinides repaglinide
action
stimulates insulin secretion
delays digestion of complex of carbohydrates
decreases postprandial rise in blood glucose
inhibit ATP sensitive potassium channels in beta cells
adverse effects
gastrointestinal symptoms like flatulence
cramps
abdominal distention
hypoglcaemia
weight gain
indications
delays carbohydrates absorption
control postprandial hyperglycaemia
provide cardiovascular benefit
dosage
25mg three time a day orally
contraindication
hypersensitivity to the drug
diabetic ketoacidosis
cirrhosis
inflammatory bowel desease
colonic ulceration
partial intestinal obstruction
chronic intestinal desease
storage
kept in a tight container
route
orally